Originally posted on 3/6/2014
Leading pharmaceutical company Astellas Pharma Inc. has upgraded to Global Member. Astellas, a long-time corporate member of ASAP, intends to use this upgrade to elevate its practice of alliance management, particularly within the healthcare industry.
“Strategic partnerships are critical in enabling Astellas to meet the unmet medical needs of patients around the world, through innovative and reliable pharmaceutical products,” said Chihiro Yokota, global head of business development and licensing & alliances for Astellas. “This move strengthens our ability to collaborate effectively and helps Astellas maximize the value of our partnerships.”
Astellas, located in Tokyo, is a pharmaceutical company dedicated to improving the health of people around the world by providing innovative pharmaceuticals. (For more information on Astellas Pharma Inc., go to its website
). Astellas has been a long-time contributor and influential presence within the ASAP community. For example, Percival Barretto-Ko, Astellas' senior vice president of corporate strategy and government affairs, was keynote presenter at the 2012 ASAP BioPharma Conference.
“Partnerships are essential to the future of the biopharmaceutical industry,” said Michael Leonetti
, president and CEO of ASAP, “and Astellas’ increased commitment to ASAP helps this association support the ever-expanding wave of partnership and collaboration that is sweeping across life sciences and healthcare -- as well as virtually every other industry and sector. Astellas and other leading alliance management practitioners turn to ASAP for the learning, community, and tools they need. We’re proud to play an important role in helping Astellas maximize the value and performance of its strategic partnerships.”
To read the full press release on Astellas’ upgrade to global member, officially announced today, visit PRWeb